Novavax, Inc. (NVAX) Profit Margins
Over the twelve months to 2026-06-30, Novavax, Inc. (NVAX) had gross margin 78.6%, operating margin -56.6%, net margin -59.9%, free cash flow margin -10.4%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NVAXNovavax, Inc.Follow NVAX — free
—
Price chart with a free account
- Market cap
- 1.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | 54.5% | 65.1% | 70.3% | 93.5% | 78.6% | |
| Operating margin | -134.4% | -250.7% | -273.0% | -433.8% | -1752.8% | -550.8% | -507.2% | -646.1% | -87.6% | -147.1% | -32.5% | -57.6% | -36.5% | 40.3% | -56.6% | |
| Net margin | -129.1% | -248.5% | -270.5% | -432.9% | -1823.5% | -589.5% | -538.8% | -711.0% | -87.9% | -152.1% | -33.2% | -55.4% | -27.5% | 39.2% | -59.9% | |
| FCF margin | -102.2% | -244.5% | -242.3% | -398.2% | -1804.0% | -476.9% | -543.0% | -742.0% | -20.4% | 23.2% | -25.7% | -78.6% | -14.9% | -22.3% | -10.4% |
USD billions · SEC XBRL
Novavax, Inc. — questions
- What is Novavax, Inc.'s gross margin?
- 78.6% over the twelve months to 2026-06-30.
- What is Novavax, Inc.'s operating margin?
- -56.6% over the twelve months to 2026-06-30.
- What is Novavax, Inc.'s net profit margin?
- -59.9% over the twelve months to 2026-06-30.
Every figure on this page comes from Novavax, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.